
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Copper homeostasis and cuproptosis in cancer immunity and therapy
Wei‐Qing Liu, Wanrong Lin, Yan Li, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 211-227
Open Access | Times Cited: 50
Wei‐Qing Liu, Wanrong Lin, Yan Li, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 211-227
Open Access | Times Cited: 50
Showing 1-25 of 50 citing articles:
Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy
Xufeng Lu, Xiaohong Chen, Chengyin Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 55
Xufeng Lu, Xiaohong Chen, Chengyin Lin, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 55
Nanoparticles Synergize Ferroptosis and Cuproptosis to Potentiate Cancer Immunotherapy
Youyou Li, Jing Liu, Yimei Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 44
Youyou Li, Jing Liu, Yimei Chen, et al.
Advanced Science (2024) Vol. 11, Iss. 23
Open Access | Times Cited: 44
Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases
Zhibo Yang, Ridong Feng, Zhao Hai
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1330-1360
Closed Access | Times Cited: 12
Zhibo Yang, Ridong Feng, Zhao Hai
APOPTOSIS (2024) Vol. 29, Iss. 9-10, pp. 1330-1360
Closed Access | Times Cited: 12
Research progress on cuproptosis in cancer
Qingbo Feng, Chenyu Huo, Maijian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Qingbo Feng, Chenyu Huo, Maijian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy – Significance for cancer treatment?
Mateusz Kciuk, Adrianna Gielecińska, Żaneta Kałuzińska‐Kołat, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189124-189124
Open Access | Times Cited: 8
Mateusz Kciuk, Adrianna Gielecińska, Żaneta Kałuzińska‐Kołat, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189124-189124
Open Access | Times Cited: 8
Advances in cuproptosis harnessing copper-based nanomaterials for cancer therapy
Yuanying Yang, Chen Dong, Xuehua Ma, et al.
Journal of Materials Chemistry B (2025)
Closed Access | Times Cited: 1
Yuanying Yang, Chen Dong, Xuehua Ma, et al.
Journal of Materials Chemistry B (2025)
Closed Access | Times Cited: 1
Construction of a novel cuproptosis-related gene signature and integrative analyses in cholangiocarcinoma
Liye Wang, Pan Li, Shuai Gong, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41600-e41600
Closed Access
Liye Wang, Pan Li, Shuai Gong, et al.
Heliyon (2025) Vol. 11, Iss. 1, pp. e41600-e41600
Closed Access
Cu-Mn Nanocomposite for Enhanced Tumor Cuproptosis achieved by Remodeling the Tumor Microenvironment and Activating the Antitumor Immunogenic Responses
Mengke Fan, Pan‐Chyr Yang, Linlin Huo, et al.
Acta Biomaterialia (2025)
Closed Access
Mengke Fan, Pan‐Chyr Yang, Linlin Huo, et al.
Acta Biomaterialia (2025)
Closed Access
DLAT is involved in ovarian cancer progression by modulating lipid metabolism through the JAK2/STAT5A/SREBP1 signaling pathway
Hui Wang, Shen Luo, Yue Yin, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Hui Wang, Shen Luo, Yue Yin, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer
Yinghao He, Fuqiang Liu, Qingshu Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0307013-e0307013
Open Access
Yinghao He, Fuqiang Liu, Qingshu Li, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0307013-e0307013
Open Access
Chemoselective and laser cleavable probes for in situ protein lipoylation detection by laser desorption/ionization mass spectrometry
Qiuyao Du, Yu Xi, Ke Jia, et al.
Chemical Science (2025)
Open Access
Qiuyao Du, Yu Xi, Ke Jia, et al.
Chemical Science (2025)
Open Access
Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities
Dan Shan, Song Jinling, Yuqing Ren, et al.
Cancer Communications (2025)
Open Access
Dan Shan, Song Jinling, Yuqing Ren, et al.
Cancer Communications (2025)
Open Access
A self-accelerating ‘copper bomb’ strategy activated innate and adaptive immune response against triple-negative breast cancer
Xinzhi Xu, Hang Zhou, Ruixia Hong, et al.
Bioactive Materials (2025) Vol. 49, pp. 193-206
Closed Access
Xinzhi Xu, Hang Zhou, Ruixia Hong, et al.
Bioactive Materials (2025) Vol. 49, pp. 193-206
Closed Access
Cell death in tumor microenvironment: an insight for exploiting novel therapeutic approaches
Wenxin Wang, Tong Li, Kui Wu
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Wenxin Wang, Tong Li, Kui Wu
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Functional nanozyme system for synergistic tumor immunotherapy via cuproptosis and ferroptosis activation
Lina Gu, Ying Sun, Tingjie Bai, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Lina Gu, Ying Sun, Tingjie Bai, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Gut microbiota in cancer: From molecular mechanisms to precision medicine applications
Weihua Xiao, Qiong Chen, Chunjiao Liu, et al.
iMeta (2025)
Open Access
Weihua Xiao, Qiong Chen, Chunjiao Liu, et al.
iMeta (2025)
Open Access
Targeting regulated cell death: Apoptosis, necroptosis, pyroptosis, ferroptosis, and cuproptosis in anticancer immunity
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Ziyu Guo, Yihuang Liu, Danyao Chen, et al.
Journal of Translational Internal Medicine (2025) Vol. 13, Iss. 1, pp. 10-32
Closed Access
Exploring cell death pathways in oral cancer: mechanisms, therapeutic strategies, and future perspectives
Chenyi Zhao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Chenyi Zhao
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Based on bimetallic Fe Co MOFs electrochemical sensor with a low detection limit for trace copper ions detection
Ruiying Zhu, Lifeng Ding, Qiang Li, et al.
Results in Chemistry (2025), pp. 102266-102266
Open Access
Ruiying Zhu, Lifeng Ding, Qiang Li, et al.
Results in Chemistry (2025), pp. 102266-102266
Open Access
The functions of cuproptosis in gastric cancer: therapy, diagnosis, prognosis
Zhiqin Zhang, Shenhua Shao, Hao Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117100-117100
Open Access | Times Cited: 3
Zhiqin Zhang, Shenhua Shao, Hao Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 117100-117100
Open Access | Times Cited: 3
Drivers of cancer metastasis – Arise early and remain present
Dagmara Dymerska, Anna A. Marusiak
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 2, pp. 189060-189060
Open Access | Times Cited: 7
Dagmara Dymerska, Anna A. Marusiak
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 2, pp. 189060-189060
Open Access | Times Cited: 7
IGSF8 is a potential target for the treatment of Gliomas
Jiaxing Ren, Ping Huang, Fei Wang
Asian Journal of Surgery (2024) Vol. 47, Iss. 9, pp. 3883-3891
Open Access | Times Cited: 2
Jiaxing Ren, Ping Huang, Fei Wang
Asian Journal of Surgery (2024) Vol. 47, Iss. 9, pp. 3883-3891
Open Access | Times Cited: 2
Cuproptosis in stroke: focusing on pathogenesis and treatment
Liwei Xing, Zhifeng Wang, Zhihui Hao, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 2
Liwei Xing, Zhifeng Wang, Zhihui Hao, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 2
Cuproptosis and Cuproptosis‐Based Synergistic Therapy for Cancer Treatment
Zhiyang Shen, Yu Qiu, Haizhen Ding, et al.
ChemMedChem (2024) Vol. 19, Iss. 21
Closed Access | Times Cited: 2
Zhiyang Shen, Yu Qiu, Haizhen Ding, et al.
ChemMedChem (2024) Vol. 19, Iss. 21
Closed Access | Times Cited: 2
A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer
Zhongkai Zhao, Zeyu Miao, Yuyang Hou, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112691-112691
Open Access | Times Cited: 2
Zhongkai Zhao, Zeyu Miao, Yuyang Hou, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112691-112691
Open Access | Times Cited: 2